About this trial
The aim of this study is to comprehensively understand the disease control and management status of children with asthma in China, as well as the types of airway inflammation. The findings of this survey will help improve the asthma control level in Chinese children, facilitate future patient education, and guide rational medication use. Moreover, it will provide important evidence for health decision-making departments to better allocate and utilize medical resources.
Eligibility criteria
Qualifiers
Age between 2 and 18 years old
Diagnosed with asthma for more than 3 months
Had asthma symptoms or asthma treatment within the past 12 months.
Disqualifiers
With other respiratory diseases such as bronchiectasis, bronchiolitis, cystic fibrosis, and pneumonia
Have participated in any interventional clinical studies related to asthma within the 3 months prior to enrollment in this study
Parents, legal representatives, or guardians do not agree to participate in this study.
Trial design
Treatments tested in this trial
- Questionnaire and Physical Exam
Treatment groups
Locations
Sponsors and collaborators
Beijing Children's Hospital
Lead sponsor
Shenzhen Children's Hospital
Sponsor institution